Synthesis and SAR exploration of dinapsoline analogues

被引:24
作者
Sit, SY
Xie, K
Jacutin-Porte, S
Boy, KM
Seanz, J
Taber, MT
Gulwadi, AG
Korpinen, CD
Burris, KD
Molski, TF
Ryan, E
Xu, C
Verdoorn, T
Johnson, G
Nichols, DE
Mailman, RB
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Neurosci Drug Discovery Chem, Wallingford, CT 06492 USA
[2] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA
[3] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Sch Med, Dept Med Chem, Chapel Hill, NC 27599 USA
关键词
dinapsoline; dopamine agonist; dopamine D-1 receptor; Parkinson's disease; SAR; dihydrexidine;
D O I
10.1016/j.bmc.2003.11.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dinapsoline is a full D-1 dopamine receptor agonist that produces robust otational activity in the unilateral 6-OHDA rat model. This compound is orally active, and shows a low tendency to cause tolerance in rat models. The active enantiomer was determined to have the S-(+) configuration, and the opposite enantiomer is essentially devoid of biological activity. Taken together, dinapsoline has significant metabolic and pharmacological advantages over previous D-1 agonists. In an attempt to define the structure-activity relationships (SARs) and to map out the key elements surrounding the unique structure of dinapsoline, core analogues and substitution analogues of the parent tetracyclic condensed ring structure were prepared. Based on a recently developed synthesis of dinapsoline and its enantiomers, both core and substitution analogues on all four rings (A, B, C and D ring) of dinapsoline were synthesized. It was found that affinity for both D-1 and D-2 receptors was decreased by most substituents on the A, B', and C rings, whereas D ring substitutions preserved much of the dopamine receptor binding activity. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:715 / 734
页数:20
相关论文
共 52 条
[1]  
[Anonymous], 1997, The dopamine receptors
[2]   The first asymmetric synthesis of a dopamine D1 agonist, dihydrexidine, employing asymmetric conjugate addition technology [J].
Asano, Y ;
Yamashita, M ;
Nagai, K ;
Kuriyama, M ;
Yamada, K ;
Tomioka, K .
TETRAHEDRON LETTERS, 2001, 42 (48) :8493-8495
[3]   EFFECTS OF REPEATED DOPAMINE-D(1) RECEPTOR STIMULATION ON ROTATION AND C-FOS EXPRESSION [J].
ASIN, KE ;
WIRTSHAFTER, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 235 (01) :167-168
[4]  
BELLAS SJ, 1964, J CHEM SOC, P4561
[5]   TRANS-10,11-DIHYDROXY-5,6,6A,7,8,12B-HEXAHYDROBENZO[A]PHENANTHRIDINE - A HIGHLY POTENT SELECTIVE DOPAMINE-D1 FULL AGONIST [J].
BREWSTER, WK ;
NICHOLS, DE ;
RIGGS, RM ;
MOTTOLA, DM ;
LOVENBERG, TW ;
LEWIS, MH ;
MAILMAN, RB .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (06) :1756-1764
[6]   EVALUATION OF CIS AND TRANS-9 AND 11-HYDROXY-5,6,6A,7,8,12B-HEXAHYDROBENZO[A]PHENANTHRIDINES AS STRUCTURALLY RIGID, SELECTIVE D-1 DOPAMINE-RECEPTOR LIGANDS [J].
BREWSTER, WK ;
NICHOLS, DE ;
WATTS, VJ ;
RIGGS, RM ;
MOTTOLA, D ;
MAILMAN, RB .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (02) :318-327
[7]   LACK OF DISCRIMINATION BY AGONISTS FOR D-2 AND D-3 DOPAMINE-RECEPTORS [J].
BURRIS, KD ;
PACHECO, MA ;
FILTZ, TM ;
KUNG, MP ;
KUNG, HF ;
MOLINOFF, PB .
NEUROPSYCHOPHARMACOLOGY, 1995, 12 (04) :335-345
[8]  
CAMPBELL NRC, 1987, MOL PHARMACOL, V32, P813
[9]  
CLARK JH, 1994, J CHEM RES
[10]   HOST-GUEST COMPLEXATION .26. CAVITANDS COMPOSED OF FLUOROBENZENE UNITS BONDED IN THEIR 2,6-POSITIONS TO FORM MACROCYCLES [J].
CRAM, DJ ;
BROWN, SB ;
TAGUCHI, T ;
FEIGEL, M ;
MAVERICK, E ;
TRUEBLOOD, KN .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1984, 106 (03) :695-701